Royal Bank of Canada Lowers SOPHiA GENETICS (NASDAQ:SOPH) Price Target to $7.00

SOPHiA GENETICS (NASDAQ:SOPH – Get Free Report) had its price target dropped by research analysts at Royal Bank of Canada from $8.00 to $7.00 in a report issued on Wednesday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Royal Bank of Canada’s price target indicates a potential upside of 102.31% from […]

Leave a Reply

Your email address will not be published.

Previous post Ukraine July 2024: BMW (+63.1%) repeats at #2, BYD (+407%) cracks Top 10
Next post Broadridge Financial Solutions (NYSE:BR) Announces Quarterly Earnings Results